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Abstract
Background: Dobutamine stress echocardiography is used to investigate a wide variety of heart
diseases in humans. Dobutamine stress echocardiography has also been used in animal models of
heart disease despite the facts that the normal response of healthy rat hearts to this type of
pharmacological stress testing is unknown. This study was performed to assess this normal
response.
Methods: 15 normal adult male Wistar rats were evaluated. Increasing doses of dobutamine were
infused intravenously under continuous imaging of the heart by a 12 MHz ultrasound probe.
Results:  Dobutamine stress echocardiography reduced gradually LV diastolic and systolic
dimensions. Ejection fraction increased by a mean of +24% vs. baseline. Heart rate increased
progressively without reaching a plateau. Changes in LV dimensions and ejection fraction reached
a plateau after a mean of 4 minutes at a constant infusion rate.
Conclusion: DSE can be easily performed in rats. The normal response is an increase in heart rate
and ejection fraction and a decrease in LV dimensions. A plateau in echocardiographic
measurements is obtained after 4 minutes of a constant infusion rate in most animals.
Introduction
Dobutamine stress echocardiography (DSE) is commonly
used in clinical practice to investigate patients with a wide
variety of cardiovascular diseases. DSE can be used for
many purposes such as to seek myocardial ischemia, eval-
uate valvular diseases, measure myocardial viability and
assess myocardial contractile reserve [1-8]. Improvements
in cardiac ultrasound imaging devices in recent years have
allowed investigators to use echocardiography in small
animals with cardiac diseases such as rats and mice and
obtain images of very good quality. Consequently,
research groups are now routinely using cardiac ultra-
sound imaging not only to investigate large animals (such
as dogs and pigs) but also small rodents. Dobutamine
stress imaging has also emerged in those small animals.
Investigators working with small animal models of car-
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diac diseases have been using dobutamine stimulation
mostly to assess myocardial contractile reserve. Accurate
interpretation of a stress test requires that the response of
normal subjects to that test is well documented. However,
there is currently no available data on the normal
response to dobutamine stimulation of the hearts of rats
and we do not know if they respond to DSE as humans do.
Therefore, the present study was designed to assess the
normal response of rat hearts to DSE.
Methods
Animals
15 adult male Wistar rats (400–450 g) were investigated.
This protocol was approved by the Université Laval's ani-
mal protection committee and was consistent with the
recommendations of the Canadian Council on animal
care.
Dobutamine Stress Echocardiography
The animals were sedated with isoflurane (2.5%,
inhaled). The femoral vein was dissected and cannulated
for the intravenous dobutamine infusion. The femoral
artery was also cannulated to measure arterial blood pres-
sure. The thorax was shaved and the animal was put on a
dorsal decubitus position. Imaging of the heart was done
using a 12 MHz ultrasound probe and a Sonos 5500 ech-
ographer (Philips Medical Imaging, Andover, MA). Imag-
ing depth was adjusted for each animal to obtain the
largest possible 2D image including the whole left ventri-
cle in the imaging sector. Harmonic imaging was used for
all the studies with optimal adjustment of gain to ensure
the best quality of images and adequate delineation of
endocardial borders. Images were stored on magneto-
optical disks for off-line analysis. Baseline measurements
were obtained under isofurane anesthesia before the
beginning of dobutamine infusion and continuous imag-
ing was done during the dobutamine test. Results were
compiled at every minute during the infusion.
2 different dobutamine infusion protocols were tested
Protocol #1
Dobutamine was infused intravenously at a constant rate
of 10 µg/kg/min until a plateau was reached in the left
ventricular (LV) ejection fraction for at least 2 minutes (n
= 10 rats). Similar doses of dobutamine infusion has been
used by others to evaluate myocardial contractile in rats
[9].
Protocol #2
Progressively increasing doses of dobutamine (5, 10 and
20 µg/kg/min) were infused in this protocol (n = 5 rats).
Each dose was infused for 4 minutes before imaging and
increasing to the next step. This protocol of progressively
increasing doses is closer to DSE protocols used in clinical
practice and has been used by other investigators [10]
using other imaging techniques.
Left ventricular dimensions and septal and posterior wall
thicknesses were obtained in the parasternal long axis
view using M-mode imaging. Relative wall thickness
(RWT) was calculated as the ratio of the sum of the wall
thicknesses (septal and posterior) to the end-diastolic
diameter. Ejection fraction was calculated using the for-
mula of Quinones et al. [11].
Statistical analysis
Results are presented as mean ± SEM unless specified oth-
erwise. Paired Student t tests were used to compare the
results at baseline with those at the end of dobutamine
infusion. One-way analysis of variance was performed to
compare serial data. Statistical significance was set at a p
value of 0.05 or less using post-hoc Tukey's test. Data and
statistical analysis were performed using GraphPad Prism
version 4.02 for Windows, GraphPad Software (San Diego
California USA).
Results
Feasibility
Dobutamine stress echocardiography was easily per-
formed in all animals and well tolerated. All animals sur-
vived the procedure and we did not encounter any
complications.
Hemodynamic response (fig. 1 and 5a)
Protocol #1
Heart rate and blood pressure response to dobutamine
infusion are displayed in figure 1. There was a constant
increase in heart rate (Baseline: 349 ± 12 bpm vs. Dob-
utamine: 424 ± 4 bpm, p < 0.01) in all the animals during
the infusion of dobutamine (fig. 1a). Systolic blood pres-
sure sharply increased after only 1 minute of infusion and
reached a plateau rapidly after (fig. 1b). We observed a
trend towards a mild increase in diastolic blood pressure
after 2 minutes of infusion but this did not reach statisti-
cal significance and diastolic pressure remained compara-
ble to baseline for the rest of the protocol (fig 1c).
Protocol #2
Animals in protocol #2 responded in a similar fashion to
protocol #1 with a progressive increase in heart rate with
each step (fig 5a), and a plateau in systolic and diastolic
pressure (not shown).
ECG monitoring
ECG was continuously monitored in 5 animals. All ani-
mals progressively developed sinus tachycardia (see
above) with dobutamine stimulation as expected. We did
not notice any ST segment change nor any form of ven-
tricular or supra-ventricular arythmia.Cardiovascular Ultrasound 2005, 3:34 http://www.cardiovascularultrasound.com/content/3/1/34
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Hemodynamic response to dobutamine infusion in rats (pro- tocol #1) Figure 1
Hemodynamic response to dobutamine infusion in rats (pro-
tocol #1). A: heart rate, B: systolic blood pressure 
(expressed as % of maximal response) and C: diastolic blood 
pressure (expressed as % of maximal response). *: p < 0.05 
vs. baseline. Data is presented are mean ± SEM.
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Left ventricular dimensions and ejection fraction during dob- utamine infusion (protocol #1) Figure 2
Left ventricular dimensions and ejection fraction during dob-
utamine infusion (protocol #1). A: End-diastolic diameter B: 
end-systolic diameter C: ejection fraction. *: p < 0.05 vs. 
baseline. Data are presented as mean ± SEM.
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LV dimensions and ejection fraction (fig. 2, 3, 4)
Protocol #1
Dobutamine infusion reduced LV dimensions as shown
in fig 2 and 3. End-diastolic dimensions (fig 2a) progres-
sively decreased compared to baseline, reaching a plateau
after 4 minutes (Baseline: 8.5 ± 0.14 mm vs. Dobutamine:
7.9 ± 0.28 mm, p < 0.01). The effects of dobutamine were
more prominent on end-systolic dimensions (fig. 2b)
with a measured decrease from 4.1 ± 0.24 mm to 2.6 ±
0.27 mm (p < 0.01). As for diastolic dimensions, a plateau
was reached in end-systolic dimensions after a mean of 4
minutes of infusion. Ejection fraction behaved similarly
with an increase from 74 ± 3.1% at baseline to 84 ± 3.6%
with dobutamine (fig. 2c). The left ventricular cavity tran-
siently remodeled in a concentric fashion during the dob-
Representative M-mode long axis view of the left ventricle at  before (t = 0) and after 6 minutes (t = 6) of dobutamine infu- sion Figure 3
Representative M-mode long axis view of the left ventricle at 
before (t = 0) and after 6 minutes (t = 6) of dobutamine infu-
sion.
t=6 min
t=0
Left ventricular wall thickness and relative wall thickness dur- ing dobutamine infusion Figure 4
Left ventricular wall thickness and relative wall thickness dur-
ing dobutamine infusion. A: septal wall (SW), B: posterior 
wall (PW) and C: relative wall thickness (RWT). Closed cir-
cles: diastolic measurements; Open circles: systolic measure-
ments. *: p < 0.05 vs. baseline. Data are presented as mean ± 
SEM.
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Dose-response effects of dobutamine infusion on the LV dimensions and ejection fraction (protocol #2) Figure 5
Dose-response effects of dobutamine infusion on the LV dimensions and ejection fraction (protocol #2). A: Heart rate, B LV 
diameters, C: septal wall, (SW). D posterior wall, (PW) E: Ejection fraction (EF) and F: relative wall thickness (RWT). Closed 
circles: diastolic measurements; Open circles: systolic measurements*: p > 0.05 vs. baseline. Data are presented as mean ± 
SEM.
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utamine infusion as depicted by the progressive increase
in relative wall thickness (fig. 4c). Diastolic septal and
posterior wall thickness were unaffected by dobutamine
whereas systolic thickening increased under dobutamine
stimulation as expected under an inotropic stimulus (fig.
4a and 4b). Significant increases in systolic thickening was
observed only after a mean of 3 minutes of dobutamine
infusion and remained constant afterwards.
Protocol #2
Findings in protocol #2 were similar to protocol #1 with
a progressive decrease in diastolic and systolic dimensions
(fig 5b), increase in systolic thickening (fig 5c–d), increase
in ejection fraction (fig 5e) and acute concentric remode-
ling (fig 5f).
Discussion
In this study, we demonstrate that dobutamine stress
echocardiography is easily feasible in rats and that rat
hearts respond to dobutamine infusion in a way that
shares strong similarities with humans. Dobutamine infu-
sion in rats is safe, quick and yields important informa-
tion about the animal's heart response to an adrenergic
stress.
Evaluating the response of the animal heart to stress in
vivo is a quite challenging task. Imaging of the heart on a
live, non sedated small animal such as a rat is virtually
impossible. Exercise imaging would be even more com-
plex. The explanted heart can be stimulated ex vivo in a
perfusion setting but the results obtained may not reflect
the reactions of the heart in the live animal. Moreover,
this type of experimentation does not allow serial evalua-
tions of the heart for obvious reasons.
Dobutamine stress echocardiography allows non-inva-
sive, serial evaluation of the heart in the live animal. DSE
is widely used in humans for the evaluation of left ven-
tricular function, contractile reserve, ischemia and viabil-
ity [1-8]. DSE has proven its usefulness in the
investigation of a wide range of cardiac diseases such as
cardiomyopathies, valvular diseases, heart failure and
ischemic heart disease. The normal response in humans is
an increase in heart rate, cardiac output and myocardial
contractility. Left ventricular dimensions normally
decrease under dobutamine stimulation as a result of the
changes in preload and afterload induced by dobutamine.
We found similar responses in our normal rats.
Dobutamine stress echocardiography has been used by
other investigators using animal models of heart disease
but mostly in large animals such as pigs and dogs [12-24].
Little data is available in smaller animals such as mice and
rats. When DSE was used in those small animals in previ-
ous studies, collected data consisted mostly of fractional
shortening or short axis cross sectional area changes or
invasive intracardiac measures of dP/dT [25-29]. The glo-
bal echocardiographic response of the heart to dob-
utamine stimulation in rats has never been described. Our
study is the first to report the normal expected dynamic
changes in healthy animals. We believe that such data is
essential to analyze the results obtained in sick animals.
We have also shown that a plateau in echocardiographic
parameters was obtained in most animals after 4 minutes
of a constant infusion rate, some animals needing up to 6
minutes. Investigators using dobutamine stimulation
should be aware of these delays to avoid underestima-
tions of the effects of the drug on the left ventricle. This is
of critical importance especially if left ventricular dimen-
sions are used to calculate fractional shortening for the
evaluation of contractile reserve.
Study limitations
The results of this study apply only to normal young adult
male Wistar rats. The response of females, youngsters,
older rats or other rodents to DSE needs to be assessed.
Contractile reserve can be easily assessed in our protocol
using a dose of 10 µg/kg/min of dobutamine as shown by
the significant increase in wall thickening and ejection
fraction but higher doses may need to be used to detect
ischemia in animal models of ischemic heart disease.
Conclusion
Dobutamine stress echocardiography can be easily per-
formed in rats and can be used to evaluate left ventricular
function in response to adrenergic stress. Sufficient time
should be allowed for the echographic parameters to sta-
bilize before any echographic measurements are made
during dobutamine stimulation in the rat. Investigators
using DSE should be aware of the normal response of the
control group of their animal model to this type of stress
testing.
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